Isabelle T.
- Country
- France
- Department
- Oncologie Médicale
Research Overview
- Evaluation of Temozolomide Monotherapy in Adult Patients with Non-Enhancing Diffuse Brainstem Gliomas Exhibiting Infiltrative Progression
- Phase II Trial of Durvalumab, Olaparib, and Fulvestrant in ER-Positive, HER2-Negative Metastatic Breast Cancer with BRCA or HRR Gene Alterations
- Efficacy and Safety of Olaparib as Adjuvant Therapy in Germline BRCA1/2 Mutated High-Risk HER2-Negative Primary Breast Cancer: A Phase III Randomized Study
Data & Insights
Has run more than one trial at 25 of 188 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in treating ER-positive, HER2-negative breast cancer, with particular emphasis on advanced and metastatic cases. Their research encompasses innovative therapeutic approaches for patients with BRCA mutations and alterations in homologous recombination repair (HRR) genes.
- Targeted Combination Therapy
- Genetic Mutation Analysis
- Adjuvant Treatment Strategies
The investigator's work extends to developing treatment protocols for high-risk breast cancer patients with germline BRCA mutations.
Neuro-Oncology
The investigator focuses on treating complex adult brainstem gliomas, particularly non-enhancing diffuse variants. Their expertise includes managing cases with infiltrative progression patterns through specialized therapeutic approaches.
- Brainstem Glioma Treatment
- Infiltrative Disease Management
- Advanced Neurological Oncology
Their work emphasizes treating non-contrast-enhancing diffuse brainstem gliomas with specific progression characteristics.
Precision Medicine
The investigator specializes in developing personalized treatment strategies based on molecular profiling and genetic markers. Their approach incorporates targeted therapies for specific genetic alterations and biomarker-driven treatment selection.
- Molecular-Based Treatment Selection
- Biomarker Analysis
- Personalized Treatment Protocols
Their research includes evaluation of treatment efficacy through specific markers such as progression-free survival and invasive disease-free survival.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.